Highly Effective 99% Molnupiravir EIDD-2801 CAS 2349386-89-4

Molnupiravir, also known as EIDD-2801, is an antiviral drug that gained attention for its potential in treating COVID-19. It was originally developed as a treatment for influenza by researchers at Emory University and Ridgeback Biotherapeutics. Molnupiravir works by interfering with the replication process of RNA viruses, including coronaviruses like SARS-CoV-2, the virus responsible for COVID-19.

The drug is a prodrug, which means it gets converted into its active form inside the body. Once metabolized, it introduces errors into the viral genetic material during replication, leading to the accumulation of mutations that can ultimately hinder the virus's ability to spread and cause infection.

Clinical trials have shown promising results in reducing viral load and symptoms in patients with mild to moderate COVID-19. However, as with any medication, further research is needed to fully understand its efficacy, safety profile, and potential side effects. As of my last update, Molnupiravir was undergoing further investigation and evaluation for its role in COVID-19 treatment.

• DHL Express, FEDEX and EMS for quantity less than 50KG, usually called as DDU service;
• Sea shipping for quantity over 500KG; and air shipping is available for 50KG above;
• For high value products, please select air shipping and DHL express for safe;
• Please confirm if you can make the clearance when goods reach your customs before placing an order, for buyers from Mexico, Turkey, Italy, Romania,Russia, and other remote area.